Another study has been observed that the ABCA3, ABCA2, MRD1, and MRP1 were significantly associated with drug resistance and increased risk of tumor relapse among a sub population of Iranian childhood ALL patients [61]. This evidence concerns the gene ABCC1 and acute lymphoblastic leukemia.